Fusion event
HBV-LOC112267863 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reference genome
AF090842.1;AB033554.1;AB014381.1;M32138.1;AB032431.1;AB036910.1;AB064310;AY090454.1
End
124162764/124292868 (Hg38)
Nearest miRNA
hsa-let-7a-2/Upstream/911356; hsa-mir-3167/Downstream/2695590;
Upstream sequence
gagtgggtcagaggtgagattgtttttctgccacatagaaggccagagctggttggagttgggtgttttctttcccccaggtcatttaggcgctgataaa
Downstream sequence
actccagcaggttaggtgctgatttaatagtttctcctgaggtcagactaagaaaaacataattcttcagaatgctttaaagtggttccttttccactcc
Target sequence
GTTGCAAGAGAAAGTCTTGTCATTACAAAACATCAAGACTTTAAGGAAAGAAAATCAATCTCTAGGTGTGCtttttttttttttcctttcttttcttgtcttAAGGAATGAGGTATCCATAGCTTGCCTGAGGATAATCCTTCACCTGTGTTTGAGATTCACAacctgctatctcaggggttttattctaacagtttcaactaacagccaaataccaatcattgccaaacctacatctctagctctgaatttttt
Zhao, L. H., et al.Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun ,2016,7: 12992.